Agios Pharmaceuticals, Inc. was incorporated in Delaware on August 7, 2007. As a pioneering biopharmaceutical company, Agios is dedicated to transforming patients' lives through its leadership in cellular metabolism, with a mission to develop differentiated therapies for rare diseases, particularly focusing on classic hematology. For more information, visit their website at http://www.agios.com. The company is headquartered at 88 Sidney Street, Cambridge, MA 02139.

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for AGIO via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.